9776 — Sapporo Clinical Laboratory Share Price
0.000.00%
Last trade - 00:00- ¥3bn
- ¥2bn
- ¥20bn
- 84
- 96
- 68
- 96
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.28 | ||
| Price to Tang. Book | 0.28 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.15 | ||
| EV to EBITDA | 1.39 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.93% | ||
| Return on Equity | 3.98% | ||
| Operating Margin | 3.25% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 17,659.08 | 17,502.54 | 19,109.6 | 20,127.69 | 19,682.32 | n/a | n/a | 2.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +18.45 | +30.54 | +39.74 | -35.68 | -52.98 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SAPPORO CLINICAL LABORATORY INC. is a Japan-based company mainly engaged in the dispensing pharmacy business. The Company operates in three business segments. The Clinical Examination segment is engaged in the provision of clinical examination needed in medical examinations in hospitals. The Dispensing Pharmacy segment is engaged in operation of dispensing pharmacies, as well as wholesale of drugs and medicines. The Medical Equipment Sale and Maintenance segment is engaged in the sale and maintenance of high level medical equipment, general medical equipment, as well as physics and chemistry equipment. The others business is engaged in the development, sale and maintenance of software for clinical examination system.
Directors
- Chuichi Date CHM (75)
- Norio Ohi PRE (63)
- Tadamasa Date VPR (41)
- Yoshihito Shoji DSL (55)
- Haruo Furusaki EXO
- Takashi Hatakeyama EXO
- Osamu Kuwabara EXO
- Shigeo Morimoto EXO
- Akihisa Shoji EXO
- Hirofumi Abe OTH (53)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 22nd, 1965
- Public Since
- April 9th, 1996
- No. of Shareholders
- 605
- No. of Employees
- 871
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 3,119,738
- Address
- 18-2-2, Kitasanjo-Nishi, Chuo-ku, SAPPORO-SHI, 060-0003
- Web
- https://www.saturin.co.jp/
- Phone
- +81 116416311
- Auditors
- Seimei Audit Corporation
Upcoming Events for 9776
Similar to 9776
Aeon Co
Tokyo Stock Exchange
Ain Holdings
Tokyo Stock Exchange
Albis Co
Tokyo Stock Exchange
ALPICO HOLDINGS CO
Tokyo Stock Exchange
Arcs Co
Tokyo Stock Exchange
FAQ
What is the Sapporo Clinical Laboratory share price?
As of Today at 23:04 UTC, shares in Sapporo Clinical Laboratory are trading at ¥982. This share price information is delayed by 15 minutes.
How has the Sapporo Clinical Laboratory share price performed this year?
Shares in Sapporo Clinical Laboratory last closed at ¥982 and the price had moved by -9.07% over the past 365 days. In terms of relative price strength the Sapporo Clinical Laboratory share price has underperformed the Nikkei 225 Index by -4.18% over the past year.
What are the analyst and broker recommendations for Sapporo Clinical Laboratory?
There is no consensus recommendation for this security.
Find out moreWhat is the Sapporo Clinical Laboratory dividend yield?
The Sapporo Clinical Laboratory dividend yield is 2.34% based on the trailing twelve month period.
Does Sapporo Clinical Laboratory pay a dividend?
Last year, Sapporo Clinical Laboratory paid a total dividend of ¥23, and it currently has a trailing dividend yield of 2.34%.Looking ahead, the next dividend pay date is 2025-06-01.
When does Sapporo Clinical Laboratory next pay dividends?
We do not have data on when Sapporo Clinical Laboratory is to next pay dividends. The historic dividend yield on Sapporo Clinical Laboratory shares is currently 2.34%.
How do I buy Sapporo Clinical Laboratory shares?
To buy shares in Sapporo Clinical Laboratory you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sapporo Clinical Laboratory?
As of the previous close price of ¥982, shares in Sapporo Clinical Laboratory had a market capitalisation of ¥3bn.
Where are Sapporo Clinical Laboratory shares listed?
Here are the trading details for Sapporo Clinical Laboratory:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 9776
What kind of share is Sapporo Clinical Laboratory?
Based on an overall assessment of its quality, value and momentum Sapporo Clinical Laboratory is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sapporo Clinical Laboratory share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Sapporo Clinical Laboratory share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sapporo Clinical Laboratory. Over the past six months, its share price has outperformed the Nikkei 225 Index by +12.24%.
As of the last closing price of ¥982, shares in Sapporo Clinical Laboratory were trading +0.7% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sapporo Clinical Laboratory PE Ratio?
The Sapporo Clinical Laboratory PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥982.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sapporo Clinical Laboratory?
Sapporo Clinical Laboratory's management team is headed by:
- Chuichi Date - CHM
- Norio Ohi - PRE
- Tadamasa Date - VPR
- Yoshihito Shoji - DSL
- Haruo Furusaki - EXO
- Takashi Hatakeyama - EXO
- Osamu Kuwabara - EXO
- Shigeo Morimoto - EXO
- Akihisa Shoji - EXO
- Hirofumi Abe - OTH